EyePoint Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
06.11.25
/
50%
€9.59
Target price
06.11.26
€33.89
Performance (%)
29.27%
Price
17.04.26
€12.10
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 29.27%. This prediction currently runs until 06.11.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| EyePoint Pharmaceuticals Inc. | 2.542% | 2.542% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (NASDAQ:EYPT) had its price target raised by analysts at Royal Bank Of Canada from $28.00 to $39.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.18
17.06.25
17.06.25
€24.24
17.06.26
17.06.26
51.63%
17.04.26
17.04.26
